(MSOS)

Cannabis ETF spent the first half of the year in the performance doldrums. But they have rallied of late on news that the Trump administration is open to reclassifying marijuana as a less dangerous dr...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

Cannabis stocks and ETFs like Amplify Alternative Harvest ETF and AdvisorShares Pure US Cannabis ETF are surging on speculation that President Trump will reclassify marijuana as a Schedule III drug. R...

July 2025 proved to be a compelling month for ETF investors, marked by a return to risk-on sentiment in some areas of the market, even as broader economic signals remained mixed.  U.S. stocks saw a st...

Trump's sweeping new tariffs on Canada, the EU, and Mexico weight on markets slightly last week. However, crypto (i.e.

MSOS has significantly underperformed the broader cannabis market, dropping 41.2% YTD versus a 27.8% sector decline. I downgraded MSOS to Strong Sell in April due to persistent risks, and the ETF has ...

MSOS holds US cannabis MSOs exclusively. It allows for exposure to US cannabis companies. US MSO stocks are historically down.

Cannabis legalization is inevitable, driven by shifting political, generational, and fiscal dynamics, especially as Republicans seek votes and tax revenue. Despite high risks, the upside for cannabis ...